Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 3, 2025International Journal For Multidisciplinary ResearchOpen Access

Liquid Biopsy in Oncology: Revolutionizing Early Detection and Monitoring

View Full Paper
Ask AI
Bookmark
Share

Authors

NGNandini GoswamiSSS. SureshJJJoy Sebastian Prakash J

Discussion

Loading...

Member takes

Overview

Observational analysis supports early detection of cancer using liquid biopsy in oncology, suggesting improved patient outcomes.

Key Points

  • Liquid biopsy enables earlier cancer detection and less invasive monitoring techniques, which may transform patient care.
  • Clinical use includes ctDNA and CTCs, with ongoing trials validating their role in minimal residual disease (MRD) surveillance.
  • Adoption of ctDNA-based tests like FoundationOne Liquid CDx shows promise for comprehensive tumor profiling in patients.
  • Liquid biopsy technologies point to a shift in oncology practices, emphasizing a need for broader implementation in routine care.

Cite This Study

Goswami et al. (2025) studied this question.

synapsesocial.com/papers/68e02f40f0e39f13e7fa2a55https://doi.org/10.36948/ijfmr.2025.v07i05.56716
View Full Paper
Ask AI
Bookmark
Share